We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

TAP Previews their New 3D Tissue Modelling System at the TERMIS and ASCB Meetings

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The new system will be previewed on Booth 201 at the TERMIS (Tissue Engineering and Regenerative Medicine International Society) Conference in Florida on December 5th-7th and on Booth 1031 at the ASCB (American Society for Cell Biology) Conference in Philadelphia on December 11th- 15th.

The simple-to-use RAFT system consists of a workstation, consumables and reagents to create consistent 3D tissue models in less than one hour. The 12-well and 24-well plate options give scientists the flexibility to produce a range of 3D tissues including multi-cellular models, barrier models and air-liquid interface cultures.  The constructs generated can be used for a wide range of cell-based assays or regenerative medicine applications.

The RAFT process has the unique ability of encapsulating viable cells in a natural 3D tissue-strength collagen environment without the use of cross-linking agents. As the cells are captured during the one hour process, there is no requirement for extensive culture periods to allow the cells to infiltrate the 3D matrix, in some cases saving two weeks or more.

Dr Grant Cameron, TAP’s newly appointed RAFT Development Director commented: “We are excited to be introducing the expanded RAFT range at these prestigious US conferences. The new 12-well system offers researchers a simple, convenient method of making larger constructs, which have broad applicability in cell biology, screening, tissue engineering, biomaterial research or regenerative medicine. The tissues produced provide cells with a more realistic environment, allowing scientists working with scarce primary cells to capture and culture these within the tissue model.”